Mundipharma fills Europe chief post
Mundipharma International, the firm behind pain treatment brands such as OxyContin and Palladone SR, has filled its newly created European comms manager role with Lara Dow.
She moves from Mundipharma associate company Napp Pharmaceuticals, where she has worked for more than a decade.
Most recently she has overseen a comms campaign to launch pain treatment BuTrans, touted as its most important product in ten years.
At Mundipharma – which won In-House Team of the Year at this year's Communiqué Awards (PRWeek, 5 August) – she will handle work ranging from brand comms and medical education to issues management and internal comms.
